The CDC reports that half of all adults with an ADHD diagnosis received the diagnosis in adulthood. "There is an increase in ...

Inc. (TSX: GUD) ("Knight"), a pan-American (ex-USA) specialty pharmaceutical company, announced today that Health Canada has approved JORNAY PM™, an extended-release formulation of methylphenidate, a ...

About half of the estimated 15.5 million American adults who have ADHD were diagnosed during adulthood. UAB’s Rachel Fargason ...

However, caffeine shouldn't be considered a treatment for ADHD and it should be used with care. Too much can cause unwanted ...

Adults with attention-deficit/hyperactivity disorder (ADHD) are more frequently presenting for diagnosis and treatment. Medication is considered to be appropriate ...

Unable to focus and only now realizing why, adults are being diagnosed with Attention Deficit Hyperactive Disorder more than ...

An estimated 15.5 million U.S adults had a current diagnosis of attention-deficit/hyperactivity disorder (ADHD) in 2023.

Women and ADHD: Women with ADHD are more likely to exhibit inattentive symptoms such as daydreaming, trouble focusing, and ...

A person with attention deficit hyperactivity disorder (ADHD) lacks the ability to pay attention, stay focussed, is overly active and may act impulsively. It is common to think ADHD affects mostly ...

An ADHD rating scale is an umbrella term for tools used to help patients, families, educators and clinicians assess and ...